Patents by Inventor Heiko Van Der Kuip

Heiko Van Der Kuip has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Device for cultivating tissue sections
    Patent number: 11459533
    Abstract: A device for cultivating tissue sections, in particular for testing active ingredients and/or medications, includes a frame, at least one carrier component designed to hold a tissue section, and at least one liquid-absorbing strip element. The frame is designed to hold the at least one carrier component and the at least one strip element. A cultivation system includes the device for cultivating tissue sections and a holding vessel. The device can be used for testing active ingredients or medications on a tissue (section).
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: October 4, 2022
    Assignee: Robert Bosch Gesellschaft Für Medizinische Forshung mbH
    Inventors: Meng Dong, Matthias Schwab, Heiko van der Kuip
  • Device for Cultivating Tissue Sections
    Publication number: 20200231916
    Abstract: A device for cultivating tissue sections, in particular for testing active ingredients and/or medications, includes a frame, at least one carrier component designed to hold a tissue section, and at least one liquid-absorbing strip element. The frame is designed to hold the at least one carrier component and the at least one strip element. A cultivation system includes the device for cultivating tissue sections and a holding vessel. The device can be used for testing active ingredients or medications on a tissue (section).
    Type: Application
    Filed: July 13, 2018
    Publication date: July 23, 2020
    Inventors: Meng Dong, Matthias Schwab, Heiko van der Kuip
  • RNAi Modulation of the BCR-ABL Fusion Gene and Uses Thereof
    Publication number: 20110251263
    Abstract: The invention relates to compositions and methods for modulating the expression of Bcr-Abl, and more particularly to the down-regulation of Bcr-Abl mRNA and Bcr-Abl protein levels by oligonucleotides via RNA interference, e.g., chemically modified oligonucleotides.
    Type: Application
    Filed: June 22, 2011
    Publication date: October 13, 2011
    Inventors: Philipp Hadwiger, Hans-Peter Vornlocher, Heiko Van Der Kuip
  • RNAi modulation of the BCR-ABL fusion gene and uses thereof
    Patent number: 7994307
    Abstract: The invention relates to compositions and methods for modulating the expression of Bcr-Abl, and more particularly to the down-regulation of Bcr-Abl mRNA and Bcr-Abl protein levels by oligonucleotides via RNA interference, e.g., chemically modified oligonucleotides.
    Type: Grant
    Filed: July 27, 2009
    Date of Patent: August 9, 2011
    Assignee: Alnylam Pharmaceuticals, Inc.
    Inventors: Philipp Hadwiger, Hans-Peter Vornlocher, Heiko Van Der Kuip
  • RNAi Modulation of the BCR-ABL Fusion Gene and Uses Thereof
    Publication number: 20100234446
    Abstract: The invention relates to compositions and methods for modulating the expression of Bcr-Abl, and more particularly to the down-regulation of Bcr-Abl mRNA and Bcr-Abl protein levels by oligonucleotides via RNA interference, e.g., chemically modified oligonucleotides.
    Type: Application
    Filed: July 27, 2009
    Publication date: September 16, 2010
    Inventors: Philipp Hadwiger, Hans-Peter Vornlocher, Heiko Van Der Kuip
  • RNAi MODULATION OF THE BCR-ABL FUSION GENE AND USES THEREOF
    Publication number: 20080293662
    Abstract: The invention relates to compositions and methods for modulating the expression of Bcr-Abl, and more particularly to the down-regulation of Bcr-Abl mRNA and Bcr-Abl protein levels by oligonucleotides via RNA interference, e.g., chemically modified oligonucleotides.
    Type: Application
    Filed: July 10, 2008
    Publication date: November 27, 2008
    Applicant: ALNYLAM PHARMACEUTICALS, INC.
    Inventors: Philipp Hadwiger, Hans-Peter Vornlocher, Heiko van der Kuip
  • RNAi modulation of the BCR-ABL fusion gene and uses thereof
    Publication number: 20060287264
    Abstract: The invention relates to compositions and methods for modulating the expression of Bcr-Abl, and more particularly to the down-regulation of Bcr-Abl mRNA and Bcr-Abl protein levels by oligonucleotides via RNA interference, e.g., chemically modified oligonucleotides.
    Type: Application
    Filed: November 23, 2005
    Publication date: December 21, 2006
    Inventors: Philipp Hadwiger, Hans-Peter Vornlocher, Heiko Van Der Kuip